Trade GMAB stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Genmab A/S ADS (GMAB) is trading at US$34.74, up 0.59% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$20.56B. Over the past 52 weeks, GMAB has traded between US$23.62 and US$35.43. On Syfe you can trade GMAB with $0 commission and add it to your watchlist.
| Previous close | US$34.54 |
|---|---|
| Market cap | US$20.56B |
| P/E ratio | 22.01 |
| 52-week range | US$23.62 – US$35.43 |
| Volume | 2.71M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Genmab A/S ADS
Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease, and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998, and is headquartered in Copenhagen, Denmark.
Year: 2010
BNP Paribas Initiates Genmab at Outperform, With $40 Price Target
Aug 12, 10:56 AM · MT Newswires
TD Cowen Upgrades Genmab to Buy From Hold, Raises Price Target to $43 From $32
Jul 22, 11:25 AM · MT Newswires
Genmab's Darzalex Generates $4.21 Billion in Q2 Net Trade Sales
Jul 15, 11:20 AM · MT Newswires
Exchange-Traded Funds Lower, Equity Futures Mixed Amid Caution Over Chip Sector Outlook
Jul 7, 1:22 PM · MT Newswires
Sector Update: Healthcare Stocks Rise Pre-Bell Tuesady
Jul 7, 1:16 PM · MT Newswires
Genmab A/S ADS (GMAB) stock is trading at US$34.74, +0.59% from the previous close of US$34.54.
The market cap for Genmab A/S ADS (GMAB) stock is approximately US$20.56B.
The price-to-earnings ratio for Genmab A/S ADS (GMAB) is 22.01, based on the latest reported earnings.
The 52-week high for Genmab A/S ADS (GMAB) stock is US$35.43.
The 52-week low for Genmab A/S ADS (GMAB) stock is US$23.62.
Genmab A/S ADS (GMAB) does not currently pay a dividend.
Stay on top of GMAB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
